Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wushen Decoction vs colchicine in acute gouty arthritis
ChiCTR2600124006Phase 2Completed
- Sponsor
- Binzhou Hospital of Traditional Chinese Medicine
- Start
- May 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Wushen Decoction in acute gout flare (2 arms), sponsored by Binzhou Hospital of Traditional Chinese Medicine. Primary endpoints: Interleukin-6 (IL-6) at 4 weeks, Tumor necrosis factor-alpha (TNF-α) at 4 weeks and 3 more. Started May 2026; status: completed.
02
Drugs
Wushen Decoction
03
Conditions
acute gout flare
Beyond the preview
Go deeper on ChiCTR2600124006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124006.